<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40699521</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1868-4297</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cardiovascular intervention and therapeutics</Title><ISOAbbreviation>Cardiovasc Interv Ther</ISOAbbreviation></Journal><ArticleTitle>Comparison of the incidence of slow flow following rotational atherectomy to severely calcified coronary artery lesions between short single session and long single session strategies: the randomized ROTASOLO trial.</ArticleTitle><Pagination><StartPage>827</StartPage><EndPage>839</EndPage><MedlinePgn>827-839</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12928-025-01177-8</ELocationID><Abstract><AbstractText>Slow flow is the most common complication of rotational atherectomy (RA). Compared with long single sessions, short single sessions may reduce the incidence of slow flow just after RA. This study aimed to compare the incidence of slow flow just after RA between short single session and long single session strategies. This multicenter, 1:1 randomized clinical trial was conducted at 3 hospitals in Japan. The short single session strategy was defined as repeating short single sessions (up to 15&#xa0;s) of RA, whereas the long single session strategy was defined as repeating long single sessions (20-30&#xa0;s) until the burr crossed the target lesion. The primary outcome was slow flow just after RA, which was defined as [(initial TIMI-frame count before RA)&#x2009;&#xd7;&#x2009;1.1 minus (TIMI-frame count just after RA)] less than 0. During the study period, 266 patients were included in the final study population and were randomly assigned to the Short single session group (n&#x2009;=&#x2009;132) or the long single session group (n&#x2009;=&#x2009;134). The protocol adherence rate was equally high in both groups (Short single session: 98.5% versus long single session 94.8%, p&#x2009;=&#x2009;0.172). The incidence of slow flow just after RA was similar between the 2 groups (short single session:14.4% versus long single session: 14.9%, p&#x2009;&gt;&#x2009;0.999). In conclusion, this randomized trial did not show a benefit of the short single session strategy compared with the long single session strategy in RA with respect to the prevention of slow flow (Unique identifier: UMIN000047231).</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sakakura</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3566-0394</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan. ksakakura@jichi.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jinnouchi</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>Yousuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Kei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsurumaki</LastName><ForeName>Yoshimasa</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, JCHO Saitama Medical Center, Saitama City, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsukui</LastName><ForeName>Takunori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mase</LastName><ForeName>Takaaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Nerima-Hikarigaoka Hospital, Nerima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seguchi</LastName><ForeName>Masaru</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasahara</LastName><ForeName>Taku</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatori</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishibashi</LastName><ForeName>Shun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamanaha</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Nerima-Hikarigaoka Hospital, Nerima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arao</LastName><ForeName>Kenshiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Nerima-Hikarigaoka Hospital, Nerima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Norifumi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, JCHO Saitama Medical Center, Saitama City, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Hideo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, 1-847 Amanuma, Omiya, Saitama City, 330-8503, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22K12892</GrantID><Agency>JSPS KAKENHI</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Cardiovasc Interv Ther</MedlineTA><NlmUniqueID>101522043</NlmUniqueID><ISSNLinking>1868-4297</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017225" MajorTopicYN="Y">Atherectomy, Coronary</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061205" MajorTopicYN="Y">Vascular Calcification</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">Randomized control study</Keyword><Keyword MajorTopicYN="N">Rotational atherectomy</Keyword><Keyword MajorTopicYN="N">Slow flow</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: Dr. Sakakura has received speaking honoraria from Boston Scientific; he has served as a proctor for Rotablator for Boston Scientific; and he has served as a consultant for Boston Scientific. Dr. Jinnouchi and Dr. Taniguchi have received speaking honoraria from Boston Scientific. Dr. Yamamoto has received speaking honoraria from Boston Scientific, and has served as a consultant for Boston Scientific.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>0</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40699521</ArticleId><ArticleId IdType="pmc">PMC12432047</ArticleId><ArticleId IdType="doi">10.1007/s12928-025-01177-8</ArticleId><ArticleId IdType="pii">10.1007/s12928-025-01177-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bourantas CV, Zhang YJ, Garg S, Iqbal J, Valgimigli M, Windecker S, et al. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials. Heart. 2014;100(15):1158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">24846971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima H, Serruys PW, Hara H, Ono M, Gao C, Wang R, et al. 10-year all-cause mortality following percutaneous or surgical revascularization in patients with heavy calcification. JACC Cardiovasc Interv. 2022;15(2):193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">34973904</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill WW. Mechanical rotational atherectomy. Am J Cardiol. 1992;69(15):12f-f18.</Citation><ArticleIdList><ArticleId IdType="pubmed">1621645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomey MI, Kini AS, Sharma SK. Current status of rotational atherectomy. JACC Cardiovasc Interv. 2014;7(4):345&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">24630879</ArticleId></ArticleIdList></Reference><Reference><Citation>Allali A, Abdel-Wahab M, Elbasha K, Mankerious N, Traboulsi H, Kastrati A, et al. Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials. Clin Res Cardiol. 2023;112(9):1143&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10450020</ArticleId><ArticleId IdType="pubmed">35482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RF, Patel MP, Abbott JD, Bangalore S, Brilakis ES, Croce KJ, et al. SCAI expert consensus statement on the management of calcified coronary lesions. J Soc Cardiovasc Angiogr Interv. 2024;3(2): 101259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11307856</ArticleId><ArticleId IdType="pubmed">39132214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikari Y, Saito S, Nakamura S, Shibata Y, Yamazaki S, Tanaka Y, et al. Device indication for calcified coronary lesions based on coronary imaging findings. Cardiovasc Interv Ther. 2023;38(2):163&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10020240</ArticleId><ArticleId IdType="pubmed">36780124</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Kuriyama N, Tanaka Y, Yamazaki S, Kawasaki T, Muramatsu T, et al. Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry. Cardiovasc Interv Ther. 2025. 10.1007/s12928-025-01130-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12167257</ArticleId><ArticleId IdType="pubmed">40354027</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JH, Kim SH, Kim BW, Bong U, Sohn CB. Successful management of iatrogenic arterial pseudoaneurysm caused by rotational atherectomy. Cardiovasc Interv Ther. 2022;37(2):391&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34117980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Ako J, Momomura S. Successful removal of an entrapped rotablation burr by extracting drive shaft sheath followed by balloon dilatation. Catheter Cardiovasc Interv. 2011;78(4):567&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">21780279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Taniguchi Y, Tsukui T, Yamamoto K, Momomura SI, Fujita H. Successful removal of an entrapped rotational atherectomy burr using a soft guide extension catheter. JACC Cardiovasc Interv. 2017;10(24):e227&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29153503</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Sakakura K, Fujita H. Simple bailout method for burr entrapment in rotational atherectomy. Cardiovasc Interv Ther. 2025. 10.1007/s12928-025-01107-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">40021572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Taniguchi Y, Yamamoto K, Tsukui T, Jinnouchi H, Seguchi M, et al. Modifiable and unmodifiable factors associated with slow flow following rotational atherectomy. PLoS ONE. 2021;16(4): e0250757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075266</ArticleId><ArticleId IdType="pubmed">33901249</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;bler P, Zimoch W, Kosowski M, Tomasiewicz B, Rakotoarison O, Telichowski A, et al. The use of rotational atherectomy in high-risk patients: results from a high-volume centre. Kardiol Pol. 2018;76(9):1360&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29974449</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuo H, Watanabe S, Watanabe T, Warita S, Kojima T, Hirose T, et al. Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy&#x2014;a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil. Am Heart J. 2007;154(5):994.e1-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17967610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong XL, Li Y, Fu GS, Zhang WB. Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy. Catheter Cardiovasc Interv. 2022;99(Suppl 1):1440&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35077596</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz K, Lovatt S, Borovac JA, Parasuraman S, Kwok CS. Planned versus bailout rotational atherectomy: a systematic review and meta-analysis. Cardiovasc Revasc Med. 2022;39:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">34627732</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#x142;aszkiewicz M, Florek K, Zimoch W, K&#xfc;bler P, Wa&#x144;ha W, Wojakowski W, et al. Predictors of periprocedural myocardial infarction after rotational atherectomy. Postepy Kardiol Interwencyjnej. 2024;20(1):62&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11008506</ArticleId><ArticleId IdType="pubmed">38616938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma SK, Dangas G, Mehran R, Duvvuri S, Kini A, Cocke TP, et al. Risk factors for the development of slow flow during rotational coronary atherectomy. Am J Cardiol. 1997;80(2):219&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">9230167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Ito Y, Shibata Y, Okamura A, Kashima Y, Nakamura S, et al. Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics. Cardiovasc Interv Ther. 2021;36(1):1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7829233</ArticleId><ArticleId IdType="pubmed">33079355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, et al. Study design and rationale for comparison of the incidence of slow flow following rotational atherectomy to severely calcified coronary artery lesions between short single session and long single session: the randomized ROTASOLO trial. Cardiol J. 2023;30(3):483&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10287080</ArticleId><ArticleId IdType="pubmed">37165803</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022;399(10324):521&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8782575</ArticleId><ArticleId IdType="pubmed">35074136</ArticleId></ArticleIdList></Reference><Reference><Citation>Capell WH, Barnathan ES, Piazza G, Spyropoulos AC, Hsia J, Bull S, et al. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: the PREVENT-HD study. Am Heart J. 2021;235:12&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871775</ArticleId><ArticleId IdType="pubmed">33577800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Inohara T, Kohsaka S, Amano T, Uemura S, Ishii H, et al. Incidence and determinants of complications in rotational atherectomy: insights from the National Clinical Data (J-PCI Registry). Circ Cardiovasc Interv. 2016;9(11): e004278.</Citation><ArticleIdList><ArticleId IdType="pubmed">27974432</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Ito Y, Shibata Y, Okamura A, Kashima Y, Nakamura S, et al. Clinical expert consensus document on rotational atherectomy from the Japanese association of cardiovascular intervention and therapeutics: update 2023. Cardiovasc Interv Ther. 2023;38(2):141&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10020250</ArticleId><ArticleId IdType="pubmed">36642762</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Taniguchi Y, Yamamoto K, Wada H, Momomura SI, Fujita H. Halfway rotational atherectomy for calcified lesions: comparison with conventional rotational atherectomy in a propensity-score matched analysis. PLoS ONE. 2019;14(7): e0219289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6611662</ArticleId><ArticleId IdType="pubmed">31276531</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62(17):1563&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3890321</ArticleId><ArticleId IdType="pubmed">24135581</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbato E, Carri&#xe9; D, Dardas P, Fajadet J, Gaul G, Haude M, et al. European expert consensus on rotational atherectomy. EuroIntervention. 2015;11(1):30&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25982648</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma SK, Tomey MI, Teirstein PS, Kini AS, Reitman AB, Lee AC, et al. North American expert review of rotational atherectomy. Circ Cardiovasc Interv. 2019;12(5): e007448.</Citation><ArticleIdList><ArticleId IdType="pubmed">31084239</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnaird T, Gallagher S, Sharp A, Protty M, Salim T, Ludman P, et al. Operator volumes and in-hospital outcomes: an analysis of 7,740 rotational atherectomy procedures from the BCIS national database. JACC Cardiovasc Interv. 2021;14(13):1423&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34147386</ArticleId></ArticleIdList></Reference><Reference><Citation>Januszek R, Siudak Z, Malinowski KP, Wa&#x144;ha W, Wojakowski W, Reczuch K, et al. Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: analysis based on a large national registry. Catheter Cardiovasc Interv. 2022;99(6):1723&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">35318789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma SK, Mehran R, Vogel B, Hooda A, Sartori S, Hanstein R, et al. Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial. EuroIntervention. 2024;20(1):75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10756220</ArticleId><ArticleId IdType="pubmed">38165112</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankerious N, Richardt G, Allali A, Geist V, Kastrati A, El-Mawardy M, et al. Lower revascularization rates after high-speed rotational atherectomy compared to modified balloons in calcified coronary lesions: 5-year outcomes of the randomized PREPARE-CALC trial. Clin Res Cardiol. 2024;113(7):1051&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">38483633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Funayama H, Taniguchi Y, Tsurumaki Y, Yamamoto K, Matsumoto M, et al. The incidence of slow flow after rotational atherectomy of calcified coronary arteries: a randomized study of low speed versus high speed. Catheter Cardiovasc Interv. 2017;89(5):832&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">27453426</ArticleId></ArticleIdList></Reference><Reference><Citation>Acar E, Izci S, Donmez I, Ozgul N, Ozcan E, Kaygusuz T, et al. A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery. Herz. 2023;48(6):480&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">37401989</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakakura K, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, et al. Halftime rotational atherectomy: a unique concept for diffuse long severely calcified lesions. Cardiovasc Interv Ther. 2024;39(1):18&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10764388</ArticleId><ArticleId IdType="pubmed">37947951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>